Skip to search formSkip to main contentSkip to account menu

Reversible Inhibitors of Monoamine Oxidase

Known as: Reversible Inhibitor of Monoamine Oxidase 
RIMA shows preference for the A isoenzyme
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
The effects of cimoxatone, a reversible inhibitor of monoamine oxidase type A (MAO-A), on the deaminated metabolites of… 
2003
2003
Befloxatone is a competitive and reversible inhibitor of monoamine oxidase-A (MAOI-A). The aim of the study was to characterize… 
2001
2001
Background: A once-weekly enteric-coated formulation of fluoxetine represents a new, effective option for the long-term treatment… 
1997
1997
RS-8359 is a new reversible inhibitor of monoamine oxidase A (RIMA). With a selectivity ratio of about 2200 for (ho: A:B enzyme… 
1992
1992
The combination of TCA and MAOI began in the 1960s for some patients who did not seem responsive to either class of… 
1983
1983
Studies on amiflamine, a reversible inhibitor of monoamine oxidase type A, selective for serotonergic neurons